Updated national IM monograph on Promethazine

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

NeLM news service

Updated national IM monograph on Promethazine

Source: Medusa

Date published: 03/11/2011 10:34

Summary

by: Gill Bullock

An updated IM monograph on Promethazine is now available from the NHS injectable medicines guide website (Medusa). Please see the link below for access (registration required).

About this library entry

Category: 3.4.2 Allergen Immunotherapy (contains Omalizumab) | 4.1.1 Hypnotics | 4.6 Drugs used in nausea and vertigo | Drug Administration

NeLM area: News

Link- registration required

Link to FAQ on MEDUSA

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.

Printer Friendly Version

Related evidence

3.4.2 Allergen Immunotherapy (contains Omalizumab)

01/08/2011

Sublingual immunotherapy for treating allergic conjunctivitis

27/10/2010

NICE guidance on omalizumab for the treatment of severe persistent allergic asthma in children (TA 201)

11/05/2010

DTB: Update on Grazax for hay fever

4.1.1 Hypnotics

18/11/2011

Melatonin for non-respiratory sleep disorders in visually impaired children

28/05/2010

Sodium oxybate (Xyrem®) in the management of narcolepsy with cataplexy

26/03/2010

Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses

4.6 Drugs used in nausea and vertigo

27/02/2012

Diclofenac with or without an antiemetic for acute migraine headaches in adults

08/11/2011

SMC does not recommend aprepitant (Emend®) for the prevention of chemotherapy-induced nausea and vomiting

07/03/2011

SMC accepts fosaprepitant dimeglumine (IVEmend®) for prevention of nausea and vomiting associated with highly emetogenic cisplatin-based chemotherapy